BUNKER KEVIN D. (Chief Operating Officer) sold 5.0% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $684.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 1/11/2022ACC: 0001725160-22-000009
Officer· Chief Operating Officer
Since Apr 2020
-18.75K
Net shares
Net seller
$684.1K
Total sold
4
Open market trades
0B · 4S
5
Total transactions
18.75K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−8.75K
Price / share
—
Trade value
—
% of position
1.2%
12/30/2021
755.07K→746.32K
Common Stock
Indirect
Shares
−3.15K
Price / share
$67.24
Trade value
$211.53K
% of position
1.6%
1/10/2022
200K→196.85K
Common Stock
Indirect
Shares
−2.81K
Price / share
$68.05
Trade value
$191.01K
% of position
1.4%
1/10/2022
196.85K→194.05K
Common Stock
Indirect
Shares
−1.83K
Price / share
$69.03
Trade value
$126.66K
% of position
0.9%
1/10/2022
194.05K→192.21K
Common Stock
Indirect
Shares
−2.21K
Price / share
$70.02
Trade value
$154.89K
% of position
1.2%
1/10/2022
192.21K→190K
Total
Net shares
−18.75K
Net value
-$684.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/30/2021 | G · Gift | −8.75K | — | — | 1.2% | 755.07K | 746.32K |
| Common Stock Indirect | 1/10/2022 | S · Sale | −3.15K | $67.24 | $211.53K | 1.6% | 200K | 196.85K |
| Common Stock Indirect | 1/10/2022 | S · Sale | −2.81K | $68.05 | $191.01K | 1.4% | 196.85K | 194.05K |
| Common Stock Indirect | 1/10/2022 | S · Sale | −1.83K | $69.03 | $126.66K | 0.9% | 194.05K | 192.21K |
| Common Stock Indirect | 1/10/2022 | S · Sale | −2.21K | $70.02 | $154.89K | 1.2% | 192.21K | 190K |
| Total | −18.75K | -$684.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned350.00
Total
350.00 indirect350.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Total | 350.00 | 350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported